Compared to second generation, the use of third generation oral contraceptives has been
associated with an increased risk of venous thrombosis especially in women with the factor …

Third-generation oral contraceptives (OC) have been associated with an increased risk of
venous thrombosis compared with second-generation OC. To find an explanation for this …

Recent concern about the safety of combined oral contraceptives (OCs) with third-
generation progestagens prompted an examination of data from a population-based case …

Background Major concern was raised by an earlier study regarding oral contraceptive use
in women with the factor V Leiden mutation. A more than 30-fold increase in relative risk for …

OBJECTIVE: To investigate associations between combined hormonal contraception and
progestogen-only contraception and risks of venous thromboembolism by progestogen and …

It has been evident for over 30 years that combined oral contraceptive pills (OCP) increase
the risk of venous thromboembolism. Recently, it has been suggested that there is an …

A plausible mechanism to explain thrombotic risk differences associated with the use of
second-and third-generation oral contraceptives (OCs), particularly in carriers of factor …

Objective This article estimates the interaction between types of combined hormonal
contraception (CHC) and factor V Leiden (FVL) mutation on the risk of venous thrombosis …

Current guidelines discourage combined oral contraceptive (COC) use in women with
hereditary thrombophilic defects. However, qualifying all hereditary thrombophilic defects as …

Four epidemiologic studies showed a twofold increase in risk of deep venous thrombosis
with the use of oral contraceptives containing third-generation progestins, relative to second …